A ground-breaking Expressive Text-To-Speech platform to create emotionally resonant virtual voices

Voiseed aims to revolutionize voice production with an Expressive TTS platform that generates emotionally resonant virtual voices in multiple languages, enhancing efficiency for various industries.

Subsidie
€ 2.072.266
2022

Projectdetails

Introduction

Traditional voice production processes by voice actors in a studio environment are expensive, time-consuming, and difficult to adapt to multiple languages.

Challenges with Current Solutions

Text to speech (TTS) solutions available in the market are trying to overcome the bottlenecks in the traditional voice production pipeline, but they fail to deliver the same level of emotion and prosody of human voices.

Voiseed's Solution

To overcome these problems, Voiseed designed a ground-breaking Expressive TTS platform, driven by proprietary deep learning algorithms, to create virtual human-like voices that are emotionally resonant through a cost-efficient and time-saving process.

Service Offering

Voiseed will offer Voice as a Service so that entertainment, e-learning, and advertising companies will be enabled to generate and dub virtual voices into any target language, keeping the required prosody.

Project Goals

During the project, Voiseed aims to develop a high-quality unique expressive speech data set to release on the market a platform with more than 32 emotions in 16 languages.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.072.266
Totale projectbegroting€ 2.960.380

Tijdlijn

Startdatum1-1-2022
Einddatum30-6-2024
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • VOISEED SRLpenvoerder

Land(en)

Italy

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

A new cardioprotective drug for acute treatment of myocardial infarction

ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.

€ 2.499.999
EIC Accelerator

"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""

NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.

€ 2.306.500
EIC Accelerator

Autonomous robotics and digital TWIN to improve water network performances

The project develops a robotic inspection system for water utilities, enabling autonomous pipeline assessments to enhance water quality and sustainability through a subscription-based RaaS model.

€ 2.478.210
EIC Accelerator

Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming system

Toopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability.

€ 2.396.457

Vergelijkbare projecten uit andere regelingen

MIT R&D Samenwerking

Langer zelfstandig thuiswonen middels interactieve emotiegebonden VR learning

Virtual Assistant BV en 360Outspoken BV ontwikkelen samen een meertalig, emotie-gebonden VR-leerplatform voor thuiszorgprofessionals om leer-efficiëntie en begrip te verbeteren.

€ 112.945
MIT Haalbaarheid

AI based Voice Generation

Daisys ontwikkelt een innovatieve AI-gebaseerde spraakgeneratiemethode die natuurlijke stemmen produceert voor auditief materiaal, met instelbare toon, ter verbetering van toegankelijkheid en functionaliteit.

€ 20.000
MIT R&D Samenwerking

e-LEARN-IT

Het project ontwikkelt een in-ear leer-assistent met spraaktechnologie om gepersonaliseerd en bewegend leren te bevorderen, en ondersteunt logopedie voor kinderen met taalachterstanden.

€ 200.000
MIT Haalbaarheid

Tessa Smart Voice Control

Het project onderzoekt de haalbaarheid van de Tessa Smart Voice Control, een sociale zorgrobot die spraakproblemen helpt overwinnen voor zelfredzaamheid en ontlasting van zorgverleners.

€ 20.000